Table 2: Effects of duration of administration (Time) on horizontal locomotion.
Dose | Acute Non Enriched | Subchronic Non En-riched | F | Tukey HSD | P value |
---|---|---|---|---|---|
Mean ± S.E.M | Mean ± S.E.M | ||||
Mean ± S.E.M, VEH: Vehicle. * p<0.05 Comparison of means between acute and subchronic administration of Monosodium glutamate, n = 6. | |||||
VEH | 212.33 ± 14.6 | 165.67 ± 10.72 | 9.90 | 2.58 | 0.078 |
10 | 147.33 ± 5.86 | 197 ± 7.46 | “ | 5.42 | 0.001* |
20 | 153.17 ± 9.38 | 198.67 ± 3.94 | “ | 4.47 | 0.001* |
40 | 147.33 ± 7.21 | 264.8 ± 5.1 | “ | 13.21 | 0.001* |
80 | 202 ± 11 | 191.83 ± 4.35 | “ | 0.86 | 0.410 |
Dose | Acute Enriched | Subchronic Enriched | F | Tukey HSD | P value |
Mean ± S.E.M | Mean ± S.E.M | ||||
VEH | 289.83 ± 7.61 | 251.33 ± 6.6 | 9.90 | 3.82 | 0.001® |
10 | 268.17 ± 11.32 | 162 ± 0.73 | “ | 9.36 | 0.001® |
20 | 165.67 ± 5.75 | 261.33 ± 12.7 | “ | 6.86 | 0.001* |
40 | 250 ± 10.52 | 119.67 ± 2.32 | “ | 12.1 | 0.001® |
80 | 246.83 ± 3.67 | 157.33 ± 3.95 | “ | 16.6 | 0.001® |